Venus Medtech (Hangzhou) Inc 2021 AR2
The report highlights Venus Medtech's financial and operational performance for the fiscal year 2021, during which the company achieved a revenue of RMB 415.9 million, representing a 50.7% increase from the previous year. Key achievements include the commercialization of its TAVR products, VenusA-Valve and VenusA-Plus, which have been implanted in over 9,000 surgeries. The company also completed the acquisition of Cardiovalve, expanding its structural heart disease treatment portfolio. On the sustainability front, the company successfully implemented its ESG governance structure, achieved its 2021 environmental objectives, and actively participated in community welfare, including free health clinics and educational donations.
Company: Venus Medtech (Hangzhou) Inc
Sector: Health Care
Country: China
Year: 2021
Type: AR2
Pages: 289
Venus Medtech (Hangzhou) Inc
Annual Report
The report highlights Venus Medtech's financial and operational performance for the fiscal year 2021, during which the company achieved a revenue of RMB 415.9 million, representing a 50.7% increase from the previous year. Key achievements include the commercialization of its TAVR products, VenusA-Valve and VenusA-Plus, which have been implanted in over 9,000 surgeries. The company also completed the acquisition of Cardiovalve, expanding its structural heart disease treatment portfolio. On the sustainability front, the company successfully implemented its ESG governance structure, achieved its 2021 environmental objectives, and actively participated in community welfare, including free health clinics and educational donations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Published
Mar 31, 2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Workplace Fatalities
Employees